739297
Last Update Posted: 2024-05-09
Recruiting has ended
All Genders accepted | 15 Years-65 Years |
68 Estimated Participants | No Expanded Access |
Interventional Study | Does not accept healthy volunteers |
The Safety and Effectiveness of MK0476 (Montelukast) in Patients With Chronic Asthma (0476-388)
This study will test the safety and effectiveness of a range of doses of MK0476 (montelukast) compared to placebo on improved lung function in patients with chronic asthma.
Eligibility
Relevant conditions:
Chronic Asthma
If you aren't sure if you meet the criteria above speak to your healthcare professional. Criteria may be updated but not reflected here, do not hesitate to contact the study if you think are close to fitting criteria.
locations
Data sourced from ClinicalTrials.gov